Hospital Group-Funded Working Paper Calls for Increased 340B Visibility Among Economists 

A recent working paper called for more economists to study the 340B program, which could broaden policymakers' understanding of its impact.
There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amgen Exempts Tennessee Providers From 340B Contract Pharmacy Restrictions Despite New Law’s Carve Out

Amgen announced it will exempt Tennessee from its contract pharmacy restrictions, surprising some providers in the state due a grandfather clause in Tennessee's law.
Pharmaceutical giant Amgen recently announced it will exempt Tennessee providers from its contract pharmacy restrictions despite a carve out in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

SpecGx to Offer Covered Entities Refunds for a Record 30-Plus Years of 340B Overcharges

Mallinckrodt's subsidiary, SpecGx, will offer refunds to covered entities for over 30 years of overcharges.
SpecGx, a generic subsidiary of Mallinckrodt Pharmaceuticals, will refund 340B covered entities that purchased addiction treatment medication Methadose for above [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Health Center Group Motion Denied in 5th Circuit; Drug Industry Makes Motion in Federal Court in South Dakota 

Key briefs were filed in litigation on contract pharmacy access laws in Louisiana and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Nordisk, Merck, GSK to Refund 340B Covered Entities for Overcharges

Novo Nordisk, Merck and GSK announced they will refund covered entities following certain overcharges for 340B drugs.
Three drugmakers will refund covered entities that purchased certain 340B-priced medications following recent adjustments to their 340B drug ceiling prices. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

House GOP Lawmaker Spartz Introduces Bill That 340B Provider Advocates Say Would Drive Them Out of the Program and Potentially Force Closures

U.S. Rep. Victoria Spartz (R-Ind.) introduced the legislation (H.R. 3222), known as the “Stopping Medicare Abuses to Restore Trust in Health Care Act” or SMART Health Care Act, on May 6. 340B provider advocates strongly oppose the bill's 340B provisions.
An Indiana congresswoman recently introduced a controversial U.S. House bill that could potentially require 340B covered entities to pass all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: Key Briefs in 8th Circuit, Utah, South Dakota; Motion Filed in 5th Circuit

Key briefs and motions were filed recently in the 8th Circuit and 5th Circuit Appeals Courts, as well as federal district courts in Utah and South Dakota.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Viatris, Amgen, GSK Announce 340B Refunds; Amgen Issues NDC Change

Viatris and two other drugmakers recently issued notices to 340B covered entities.
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital, Pharmacist Advocates File Brief Backing Nebraska’s New 340B Contract Pharmacy Access Law Against AbbVie Challenge 

Hospital and pharmacist advocacy groups argued that a federal district court should uphold Nebraska's contract pharmacy access law.
Multiple hospital advocacy groups have filed an amicus brief urging a federal district judge to uphold Nebraska’s recently enacted 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AbbVie, Sobi, Organon Exempt More States from 340B Contract Pharmacy Restrictions

Organon is one of three drugmakers to recently announce new state-level exemptions to its 340B contract pharmacy restrictions.
Three drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in light of new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live